

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
We will give women everywhere control of their sexual and reproductive health.
2 des employés de chez Evofem Biosciences ont examiné Evofem Biosciences dans diverses dimensions culturelles, en donnant leur avis sur des sujets allant des évaluations des dirigeants au rythme de travail. La dernière évaluation date d'il y a mois.
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.









Lack of leadership. Very inexperienced.

Dîtes à Evofem Biosciences que vous êtes intéressé à travailler dans l'entreprise tout en maintenant votre identité personnelle anonyme. Comparably donnera à Evofem Biosciences l’occasion de vous embaucher. Quand un poste qui vous convient s'ouvrira, nous ferons le match.
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Envoyez-leur une invitation pour évaluer la culture de l’entreprise.